Cubist Systematic Strategies has reported a short position equivalent to 0.47 percent of the capital in Danish pharmaceutical company Genmab. The position is therefore below the threshold for public disclosure. The previous position was 0.5 percent.
The Danish Financial Supervisory Authority requires positions above 0.1 percent to be reported and short positions above 0.5 percent to be made public.
